Literature DB >> 2962493

Limb body wall complex: I. Pathogenesis.

M I Van Allen1, C Curry, L Gallagher.   

Abstract

Twenty-five fetuses with limb body wall complex (LBW complex) were evaluated. The diagnosis was based on two out of three of the following: exencephaly/encephalocele with facial clefts; thoraco- and/or abdominoschisis; and limb defect. Ninety-five percent (24/25) of the fetuses had associated internal structural defects. In 72% (18/25) the internal defects have been recognized as being secondary to vascular disruption. Concordance was not found between the side and location of the body wall defect versus the limb, internal, and cranial defects. In 85% there was evidence for persistence of the extraembryonic coelom by examination of the placenta. In this same group (85%) there was persistence of the ectodermal-amnion margin, with the amnion being continuous with the skin of the body wall defect. In 40% (10/25) there were tags and amniotic adhesions at other sites. There was no difference in the types or incidence of internal defects between those with and those without amniotic bands. The abnormalities in this collection and experimental animal models support vascular disruption during 4-6 weeks' gestation as an etiology for LBW complex. There is disruption and loss of existing tissues, persistence of embryonic structures, and secondary malformations. Persistence of the extraembryonic coelom may lead to the typical amniotic tags, ring constrictions, and adhesions seen in some specimens.

Entities:  

Mesh:

Year:  1987        PMID: 2962493     DOI: 10.1002/ajmg.1320280302

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  41 in total

1.  Fetal malformations caused by amnion rupture.

Authors:  F J Sheth; A S Multani; V C Shah; N J Chinoy
Journal:  Indian J Pediatr       Date:  1995 May-Jun       Impact factor: 1.967

2.  Long-term survival of a baby with body stalk anomaly: report of a case.

Authors:  Yutaka Kanamori; Kohei Hashizume; Masahiko Sugiyama; Tetsuya Tomonaga; Hajime Takayasu; Tetsuya Ishimaru; Kan Terawaki; Kan Suzuki; Keiji Goishi; Masaru Takamizawa
Journal:  Surg Today       Date:  2007-01-01       Impact factor: 2.549

3.  Omphalocele major with absent lower limb.

Authors:  Vijay Kumar Kundal; Mufique Gajdhar; Raksha Kundal; Reyaz Ahmed; Leela Dhar Agrawal
Journal:  Indian J Surg       Date:  2013-01-12       Impact factor: 0.656

4.  Epidemiology and risk factors of amniotic band syndrome, or ADAM sequence.

Authors:  Pietro Cignini; Claudio Giorlandino; Francesco Padula; Nella Dugo; Ester Valentina Cafà; Anna Spata
Journal:  J Prenat Med       Date:  2012-10

5.  Associated anomalies among infants with oral clefts at birth and during a 1-year follow-up.

Authors:  Monica Rittler; Viviana Cosentino; Jorge S López-Camelo; Jeffrey C Murray; George Wehby; Eduardo E Castilla
Journal:  Am J Med Genet A       Date:  2011-06-10       Impact factor: 2.802

6.  Prenatal MRI evaluation of limb-body wall complex.

Authors:  Elisa Aguirre-Pascual; Monica Epelman; Ann M Johnson; Nancy A Chauvin; Beverly G Coleman; Teresa Victoria
Journal:  Pediatr Radiol       Date:  2014-06-14

7.  Dichorionic twins discordant for body-stalk anomaly: a management challenge.

Authors:  Rita Caldas; Cátia Rodrigues; Carla Pina; Rosete Nogueira
Journal:  BMJ Case Rep       Date:  2018-05-12

8.  Amniotic band syndrome in dichorionic diamniotic twin pregnancy.

Authors:  A Krzyżanowski; M Kwiatek; T Gęca; B Barczyński; A Kwaśniewska
Journal:  Hippokratia       Date:  2017 Jan-Mar       Impact factor: 0.471

9.  Limb body wall complex in a still born fetus: a case report.

Authors:  Nishad Plakkal; Joseph John; Sajini Elizabeth Jacob; J Chithira; Sowmya Sampath
Journal:  Cases J       Date:  2008-08-12

10.  Fetal musculoskeletal malformations with a poor outcome: ultrasonographic, pathologic, and radiographic findings.

Authors:  Soo Hyun Lee; Jeong Yeon Cho; Mi Jin Song; Jee Yeon Min; Byoung Hee Han; Young Ho Lee; Byung Jae Cho; Seung Hyup Kim
Journal:  Korean J Radiol       Date:  2002 Apr-Jun       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.